RSS Items

Lupin announced that it has entered into an exclusive licensing agreement with U.S.-based biosimilar specialist Valorum Biologics for its biosimilar Armlupeg (pegfilgrastim-unne).

The product will be manufactured at Lupin's Biotech facility in Pune, which was inspected by the U.S. FDA prior to approval.

Lupin announced that it has received tentative approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Siponimod Tablets in 0.25 mg, 1 mg and 2 mg.

Mahindra & Mahindra Ltd has added 5.42% over last one month compared to 4.17% gain in BSE Auto index and 1.4% rise in the SENSEX

Mahindra Lifespace Developers said that it has been selected as the preferred development partner for a major residential redevelopment project in Matunga, Mumbai.

With gross development value of Rs 1,010 cr

Mainboard IPO launches have hit 100 for the first time since 2007, with mobilisation set to cross Rs 1.7 trillion, powered by strong domestic inflows, steady PE exits and resilient demand

Valuation of India's largest hospital network is around $12-15 bn. The Issue will comprise fresh issue of shares and a small portion as OFS

Powered by Capital Market - Live News

Key equity indices posted modest gains today, breaking a four-day losing streak. Sentiment, however, remained fragile as the weak rupee, steady FII outflows and uncertainty ahead of the RBIs policy decision kept investors cautious. Volatility